1. Sign our petition calling on Cochrane to withdraw their review of Exercise Therapy for CFS here.
    Dismiss Notice
  2. Guest, the 'News in Brief' for the week beginning 15th April 2024 is here.
    Dismiss Notice
  3. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

antibodies

Page 1 of 2
  1. SNT Gatchaman
    Thread

    ACE-2-like enzymatic activity is associated with immunoglobulin in COVID-19 patients, 2024, Song et al.

    ACE-2-like enzymatic activity is associated with immunoglobulin in COVID-19 patients Yufeng Song; Regan Myers; Frances Mehl; Lila Murphy; Bailey...
    Thread by: SNT Gatchaman, Mar 27, 2024, 3 replies, in forum: Epidemics (including Covid-19, not Long Covid)
  2. Andy
    Thread

    Catalytic Antibodies May Contribute to Demyelination in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, 2023, Jensen, Davis et al

    Here we report preliminary data demonstrating that some patients with myalgic encephalomyelitis/chronic fatiguesyndrome (ME/CFS) may have...
    Thread by: Andy, Nov 28, 2023, 13 replies, in forum: ME/CFS research
  3. Andy
    Thread

    Persistent symptoms after COVID-19 are not associated with differential SARS-CoV-2 antibody or T cell immunity 2023 Altmann et al

    Abstract Among the unknowns in decoding the pathogenesis of SARS-CoV-2 persistent symptoms in Long Covid is whether there is a contributory role...
    Thread by: Andy, Aug 24, 2023, 3 replies, in forum: Long Covid research
  4. Jaybee00
    Thread

    Anti-SARS-CoV-2 Monoclonal Antibodies for Long COVID (COVID-19) (outSMART-LC)

    Post copied from the LC in the media thread [MEDIA]
    Thread by: Jaybee00, May 29, 2023, 2 replies, in forum: Long Covid news
  5. SNT Gatchaman
    Thread

    Free-water-corrected diffusion and adrenergic/muscarinic antibodies in myalgic encephalomyelitis/chronic fatigue syndrome, 2023, Kimura et al.

    Free-water-corrected diffusion and adrenergic/muscarinic antibodies in myalgic encephalomyelitis/chronic fatigue syndrome Yukio Kimura; Wakiro...
    Thread by: SNT Gatchaman, May 28, 2023, 2 replies, in forum: ME/CFS research
  6. SNT Gatchaman
    Thread

    SARS-CoV-2 Spike Protein Binding of Glycated Serum Albumin-Its Potential Role in the Pathogenesis of the COVID-19 Clinical Syndromes, 2022, Iles et al

    SARS-CoV-2 Spike Protein Binding of Glycated Serum Albumin-Its Potential Role in the Pathogenesis of the COVID-19 Clinical Syndromes and Bias...
    Thread by: SNT Gatchaman, Jan 14, 2023, 0 replies, in forum: Epidemics (including Covid-19, not Long Covid)
  7. SNT Gatchaman
    Thread

    Class switch towards non-inflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination, 2022, Irrgang et al

    Class switch towards non-inflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination Pascal Irrgang, Juliane Gerling,...
    Thread by: SNT Gatchaman, Dec 27, 2022, 3 replies, in forum: Epidemics (including Covid-19, not Long Covid)
  8. SNT Gatchaman
    Thread

    Biomarkers in the diagnostic algorithm of myalgic encephalomyelitis/chronic fatigue syndrome, 2022, Gravelsina et al

    Biomarkers in the diagnostic algorithm of myalgic encephalomyelitis/chronic fatigue syndrome Gravelsina Sabine, Vilmane Anda, Svirskis Simons,...
    Thread by: SNT Gatchaman, Oct 10, 2022, 11 replies, in forum: ME/CFS research
  9. LarsSG
    Thread

    Revisiting IgG antibody reactivity to Epstein-Barr virus in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome..., 2022, Sepúlveda et al

    Revisiting IgG antibody reactivity to Epstein-Barr virus in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and its potential application to...
    Thread by: LarsSG, Apr 25, 2022, 0 replies, in forum: ME/CFS research
  10. Wyva
    Thread

    Serum Level of Anti-Nucleocapsid, but Not Anti-Spike Antibody, Is Associated with Improvement of Long COVID Symptoms, 2022, Varnai et al

    Abstract Background: Long COVID is a condition characterized by long-term sequelae persisting after the typical convalescence period of COVID-19....
    Thread by: Wyva, Feb 1, 2022, 1 replies, in forum: Long Covid research
  11. ME/CFS Skeptic
    Thread

    Medscape: FDA Approves New Myasthenia Gravis Drug

    The US Food and Drug Administration (FDA) has approved efgartigimod (Vyvgart, argenx), a first-in-class, targeted therapy for adults with...
    Thread by: ME/CFS Skeptic, Dec 19, 2021, 3 replies, in forum: Other health news and research
  12. Wyva
    Thread

    Severe Fatigue and Memory Impairment Are Associated with Lower Serum Level of Anti-SARS-CoV-2 Antibodies in pw Post-COVID (...), 2021, Molnar et al

    Full title: Severe Fatigue and Memory Impairment Are Associated with Lower Serum Level of Anti-SARS-CoV-2 Antibodies in Patients with Post-COVID...
    Thread by: Wyva, Nov 12, 2021, 1 replies, in forum: Long Covid research
  13. Hoopoe
    Thread

    Predictors of Nonseroconversion after SARS-CoV-2 Infection, 2021, Liu et al

    Predictors of Nonseroconversion after SARS-CoV-2 Infection https://wwwnc.cdc.gov/eid/article/27/9/21-1042_article ____________________ CDC...
    Thread by: Hoopoe, Aug 30, 2021, 20 replies, in forum: Epidemics (including Covid-19, not Long Covid)
  14. cassava7
    Thread

    Divergent and self-reactive immune responses in the CNS of COVID-19 patients with neurological symptoms, Song et al., 2021

    Eric Song, Christopher M. Bartley, Ryan D. Chow, Thomas T. Ngo, Ruoyi Jiang, Colin R. Zamecnik, Ravi Dandekar, Rita P. Loudermilk, Yile Dai,...
    Thread by: cassava7, May 1, 2021, 1 replies, in forum: Epidemics (including Covid-19, not Long Covid)
  15. Sly Saint
    Thread

    Analysis of antibody data using Finite Mixture Models based on Scale Mixtures of Skew-Normal distributions, 2021, Domingues et al

    Preprint. " Abstract Finite mixture models have been widely used in antibody (or serological) data analysis in order to help classifying...
    Thread by: Sly Saint, Mar 10, 2021, 3 replies, in forum: ME/CFS research
  16. hinterland
    Thread

    Covid-19 vaccines and vaccinations

    The Pfizer press release reports that protection is achieved 28 days after initiation of the first dose of vaccine. Whereas you can develop covid...
    Thread by: hinterland, Dec 3, 2020, 1,284 replies, in forum: Epidemics (including Covid-19, not Long Covid)
  17. Trish
    Thread

    The biology of coronavirus COVID-19 - including research and treatments

    I have just listened to a very interesting radio program 'BBC Inside Science: Biology of the new coronavirus'. I don't know whether it's...
    Thread by: Trish, Mar 12, 2020, 1,737 replies, in forum: Epidemics (including Covid-19, not Long Covid)
  18. John Mac
    Thread

    Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Efficacy of Repeat Immunoadsorption. Tolle, Scheibenbogen et al. 2020

    Abstract (1) Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a complex neuroimmunological disease. There is evidence for an...
    Thread by: John Mac, Jul 30, 2020, 15 replies, in forum: ME/CFS research
  19. Anna H
    Thread

    Sweden planned study: Cell biological/Immunometabolic changes in myalgic encephalomyelitis, ME, Rosén et al (MECELL)

    Professor Anders Rosén and Eirini Apostolou, PhD, at Linköping University are planning a study consisting of 3 subprojects, looking at cytokines,...
    Thread by: Anna H, Jul 13, 2020, 18 replies, in forum: ME/CFS research news
  20. Dolphin
    Thread

    (Thesis) Autoimmune aspects in ME/CFS: A literature study on indications of autoimmunity in ME/CFS [Swedish), 2020, Strahle

    From: Dr. Marc-Alexander Fluks Source: Digitala Vetenskapliga Arkivet (DiVA) Date: June 23, 2020 URL:...
    Thread by: Dolphin, Jun 30, 2020, 2 replies, in forum: ME/CFS research
Showing results 1 to 20 of 30
Page 1 of 2